Home

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

All Products

Chemical Structure Cat. No. Product Name CAS No.
Quinacrine dihydrochloride Chemical Structure
BCP49707 Quinacrine dihydrochloride 69-05-6
Quinacrine (Mepacrine) dihydrochloride is an orally bioavailable antimalarial agent, which possess anticancer effect both in vitro and vivo. Quinacrine dihydrochloride suppresses NF-κB and activate p53 signaling, which results in the induction of the apoptosis.
Nicarbazin Chemical Structure
BCP49706 Nicarbazin 330-95-0
Nicarbazin is an effective anticoccidial agent for chickens.
Oxibendazole Chemical Structure
BCP49705 Oxibendazole 20559-55-1
Oxibendazole is an effective benzimidazole anthelmintic and is against nema-tode infections. Oxibendazole can induces apoptosis and has anti-cancer and anti-inflammation activities.
Stibogluconate sodium Chemical Structure
BCP49704 Stibogluconate sodium 16037-91-5
Sodium stibogluconate is a pentavalent antimony compound. It exhibits protein tyrosine phosphatase (PTPase) activity.
Bromotrimethylsilane Chemical Structure
BCP49703 Bromotrimethylsilane 2857-97-8
(22S,64S,4S)-4-amino-12-(5-(4-cyclopropylpiperazin-1-yl)-2-((S)-1-methoxyethyl)pyridin-3-yl)-10,10-dimethyl-11-(2,2,2-trifluoroethyl)-11H-8-oxa-62,63- Chemical Structure
BCP49701 (22S,64S,4S)-4-amino-12-(5-(4-cyclopropylpiperazin-1-yl)-2-((S)-1-methoxyethyl)pyridin-3-yl)-10,10-dimethyl-11-(2,2,2-trifluoroethyl)-11H-8-oxa-62,63- 123456789-01-7
Lithium(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate Chemical Structure
BCP49702 Lithium(2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate 2864383-31-1
2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid, methyl ester, (4S)- Chemical Structure
BCP49700 2,3-Diazabicyclo[3.1.1]heptane-4-carboxylic acid, methyl ester, (4S)- 3034241-21-6
Mutated EGFR-IN-1 Chemical Structure
BCP28639 Mutated EGFR-IN-1 1421372-66-8
Mutated EGFR-IN-1 is a useful intermediate for the inhibitors design for mutated EGFR, such as L858R EGFR, Exonl9 deletion activating mutant and T790M resistance mutant.
Sevabertinib Chemical Structure
BCP49699 Sevabertinib 2521285-05-0
Sevabertinib is an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor with antitumor activity.
123下一页末页共 32694 条记录 1 / 3270 页 
0086-13720134139